BE837294A - Preparations pharmaceutiques pour le traitement des troubles de la circulation - Google Patents

Preparations pharmaceutiques pour le traitement des troubles de la circulation

Info

Publication number
BE837294A
BE837294A BE163296A BE163296A BE837294A BE 837294 A BE837294 A BE 837294A BE 163296 A BE163296 A BE 163296A BE 163296 A BE163296 A BE 163296A BE 837294 A BE837294 A BE 837294A
Authority
BE
Belgium
Prior art keywords
treatment
pharmaceutical preparations
circulation disorders
disorders
circulation
Prior art date
Application number
BE163296A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE837294A publication Critical patent/BE837294A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/618Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/625Salicylic acid; Derivatives thereof having heterocyclic substituents, e.g. 4-salicycloylmorpholine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE163296A 1975-01-06 1976-01-05 Preparations pharmaceutiques pour le traitement des troubles de la circulation BE837294A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH7175 1975-01-06
CH1474775 1975-11-13

Publications (1)

Publication Number Publication Date
BE837294A true BE837294A (fr) 1976-07-05

Family

ID=25683420

Family Applications (1)

Application Number Title Priority Date Filing Date
BE163296A BE837294A (fr) 1975-01-06 1976-01-05 Preparations pharmaceutiques pour le traitement des troubles de la circulation

Country Status (10)

Country Link
JP (1) JPS5191314A (de)
AU (1) AU499139B2 (de)
BE (1) BE837294A (de)
CA (1) CA1059914A (de)
DE (1) DE2600021A1 (de)
FR (1) FR2296415A1 (de)
GB (1) GB1500300A (de)
IE (1) IE42765B1 (de)
IL (1) IL48787A (de)
NL (1) NL7600047A (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI63335B (fi) * 1979-02-02 1983-02-28 Orion Yhtymae Oy Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne
IN151913B (de) * 1980-01-11 1983-09-03 Boots Co Ltd
US5731339A (en) * 1995-04-28 1998-03-24 Zonagen, Inc. Methods and formulations for modulating the human sexual response
FI20060501L (fi) * 2006-05-22 2007-11-23 Biohit Oyj Koostumus ja menetelmä asetaldehydin sitomiseksi vatsassa
KR20090037951A (ko) * 2006-07-25 2009-04-16 교와 가부시키가이샤 당의 제제 및 그의 제조 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL51480C (de) *
FR1013681A (fr) * 1947-01-31 1952-08-01 Ciba Geigy Nouvelles imidazolines et procédé pour leur fabrication

Also Published As

Publication number Publication date
IE42765L (en) 1976-07-06
AU1000176A (en) 1977-07-14
NL7600047A (nl) 1976-07-08
IL48787A (en) 1978-09-29
FR2296415B1 (de) 1978-08-18
GB1500300A (en) 1978-02-08
AU499139B2 (en) 1979-04-05
IE42765B1 (en) 1980-10-08
CA1059914A (en) 1979-08-07
DE2600021A1 (de) 1976-07-15
FR2296415A1 (fr) 1976-07-30
IL48787A0 (en) 1976-03-31
JPS5191314A (de) 1976-08-10

Similar Documents

Publication Publication Date Title
FR2348201A1 (fr) Nouveaux medicaments pour le traitement des affections vasculaires ischemiques
FR2316954A1 (fr) Preparation dentaire pour le traitement de la parodontose
FR2333515A1 (fr) Compositions pharmaceutiques pour le traitement des troubles du metabolisme du calcium
BE854416A (fr) Compositions pharmaceutiques pour le traitement des symptomes de la menopause et leur procede d'utilisation
BE865156A (fr) Compositions pharmaceutiques pour le traitement des depressions
FR2341315A1 (fr) Medicaments pour le traitement des neuropathies
BE885291A (fr) Compositions pharmaceutiques pour le traitement des dysfonctionnements cardiaques
FR2310769A1 (fr) Medicament pour le traitement de l'alopecia seborrhoeica
BE773121A (fr) Preparations pharmaceutiques destinees au traitement des hyperlipidemies et leur procede d'obtention
FR2296415A1 (fr) Preparations pharmaceutiques pour le traitement des troubles de la circulation
FR2311553A1 (fr) Medicament pour le traitement de la schizophrenie
BE814735A (fr) Nouvelle composition pharmaceutique pour le traitement des maladies coronariennes
BE809832A (fr) Compositions pharmaceutiques pour le traitement de maladies de la peau
FR2310770A1 (fr) Medicament pour le traitement de l'alopecia areata
BE842389A (fr) Composition pharmaceutique pour le traitement de l'hyperuricemie
FR2310768A1 (fr) Medicament pour le traitement de l'alopecia senilis
FR2310767A1 (fr) Medicament pour le traitement de l'alopecia chronica diffusa
BE860239A (fr) Preparation medicinale pour le traitement des neoformations malignes
ZA7628B (en) Pharmaceutical preparation for the treatment of circulatory disorders
BE791253A (fr) Nouvelles preparations pharmaceutiques pour le traitement de l'hypertonie
BE812974A (fr) Compositions pharmaceutiques pour le traitement des ulceres
BE829024A (fr) Compositions pharmaceutiques pour le traitement de l'hydropisie
BE809833A (fr) Compositions pharmaceutiques pour le traitement des maladies proliferantes de la peau
BE786326A (fr) Nouvelles compositions pharmaceutiques pour le traitement des troubles de la secretion intestinale
BE848908A (fr) Compositions pharmaceutiques pour le traitement des troubles du metabolisme du calcium,